Pharmacokinetics of Moxifloxacin in an Infant With Mycoplasma hominis Meningitis
- 1 February 2012
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 31 (2) , 197-199
Abstract
Treatment of Mycoplasma hominis meningitis in infants is limited by a lack of consensus regarding therapy and limited pharmacokinetic data for agents to which M. hominis is susceptible. We report the successful treatment of a premature infant suffering from M. hominis meningitis with doxycycline and moxifloxacin and provide a pharmacokinetic profile of moxifloxacin.Keywords
This publication has 10 references indexed in Scilit:
- In-Vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 yearsClinical Microbiology and Infection, 2010
- In-Vitro Activities of Tetracyclines, Macrolides, Fluoroquinolones and Clindamycin againstMycoplasma hominisandUreaplasmassp. isolated in Germany over 20 yearsClinical Microbiology and Infection, 2009
- Mycoplasma hominis meningitis in a neonate: Case report and reviewJournal of Infection, 2008
- A case of Mycoplasma hominis meningo-encephalitis in a full-term infant: rapid recovery after start of treatment with ciprofloxacinEuropean Journal of Pediatrics, 2003
- The use of in vitro pharmacodynamic models of infection to optimize fluoroquinolone dosing regimensJournal of Antimicrobial Chemotherapy, 2000
- Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in manJournal of Antimicrobial Chemotherapy, 1999
- Bactericidal properties of moxifloxacin and post-antibiotic effectJournal of Antimicrobial Chemotherapy, 1999
- Seizures Occurring in Pediatric Patients Receiving Continuous Infusion of BupivacaineAnesthesia & Analgesia, 1992
- Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animalsToxicology and Applied Pharmacology, 1990
- The application of statistical moment theory to the evaluation ofin vivo dissolution time and absorption timeJournal of Pharmacokinetics and Biopharmaceutics, 1980